Five-years surveillance of invasive aspergillosis in a university hospital

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Graf, Karolin ^a   Khani, Somayeh M ^a   Ott, Ella ^a   Mattner, Frauke ^a,b   Gastmeier, Petra ^a,c   Sohr, Dorith ^c   Ziesing, Stefan ^a   Chaberny, Iris F ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b University Hospital of Witten/Herdecke   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aspergillosis; Epidemiology; Invasive; Pathology; Surveillance

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; CYCLOSPORIN; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; STEROID; VORICONAZOLE; ANTIFUNGAL AGENT;

ADULT; ARTICLE; AUTOPSY; BRONCHUS SECRETION; CANCER PATIENT; CHRONIC DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG MEGADOSE; EORTC CRITERIA; FEMALE; FUNGUS CULTURE; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INVASIVE ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN TRANSPLANTATION; PROPHYLAXIS; RISK FACTOR; STEM CELL TRANSPLANTATION; TERTIARY HEALTH CARE; TRACHEA; TRACHEAL SECRETION; TREATMENT DURATION; UNIVERSITY HOSPITAL; ASPERGILLOSIS; ASPERGILLUS; DRUG EFFECT; GERMANY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; GERMANY; HOSPITALS, UNIVERSITY; HUMANS;

EID: 79958044366     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-163     Document Type: Article

References (27)

1. Burghi G, Lemiale V, Bagnulo H, Bodega E, Azoulay E. [Invasive pulmonary aspergillosis in a hematooncological patient in the intensive care units. A review of the literature.]. Med Intensiva 2010, 34:459-66. 10.1016/j.medin.2009.11.010, 20096960.
2. Cornet M, Fleury L, Maslo C, Bernard JF, Brucker G. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect 2002, 51:288-296. 10.1053/jhin.2002.1258, 12183144.
3. Singh N, Husain S. Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 2009, 9(Suppl 4):S180-S191.
4. Mattner F, Chaberny IF, Weissbrodt H, Fischer S, Gastmeier P, Haubitz B et A. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole]. Mycoses 2005, 48(Suppl 1):51-55.
5. Blot S, Piette A, Vandijck D, Lizy C, Vandewoude K, Vogelaers D. The economic impact of invasive aspergillosis in intensive care unit patients. Int J Infect Dis 2010, 14:e536-7. 10.1016/j.ijid.2009.06.014, 19713140.
6. Weber DJ, Peppercorn A, Miller MB, Sickbert-Benett E, Rutala WA. Preventing healthcare-associated Aspergillus infections: review of recent CDC/HICPAC recommendations. Med Mycol 2009, 47(Suppl 1):S199-S209.
7. Pegues CF, Daar ES, Murthy AR. The epidemiology of invasive pulmonary aspergillosis at a large teaching hospital. Infect Control Hosp Epidemiol 2001, 22:370-374. 10.1086/501915, 11519915.
8. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010, 50:1101-1111. 10.1086/651262, 20218876.
9. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010, 50:1091-1100. 10.1086/651263, 20218877.
10. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14. 10.1086/323335, 11731939.
11. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004, 53:1-36.
12. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821. 10.1086/588660, 2671227, 18462102.
13. Fourneret-Vivier A, Lebeau B, Mallaret MR, Brenier-Pinchart MP, Brion JP, Pinel C, et al. Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000-2002). J Hosp Infect 2006, 62:22-28. 10.1016/j.jhin.2005.06.013, 16257084.
14. Chang DC, Burwell LA, Lyon GM, Pappas PG, Chiller TM, Wannemuehler KA, et al. Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis. Infect Control Hosp Epidemiol 2008, 29:25-30. 10.1086/524324, 18171183.
15. Brinkmann B, Du CA, Vennemann B. [Recent data for frequency of autopsy in Germany]. Dtsch Med Wochenschr 2002, 127:791-795. 10.1055/s-2002-25021, 11951136.
16. Erjavec Z, Kluin-Nelemans H, Verweij PE. Trends in invasive fungal infections, with emphasis on invasive aspergillosis. Clin Microbiol Infect 2009, 15:625-633. 10.1111/j.1469-0691.2009.02929.x, 19673973.
17. Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 2004, 39:797-802. 10.1086/423380, 15472810.
18. Minari A, Husni R, Avery RK, Longworth DL, DeCamp M, Bertin M, et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis 2002, 4:195-200. 10.1034/j.1399-3062.2002.t01-2-02002.x, 12535262.
19. Wingard JR, Beals SU, Santos GW, Merz WG, Saral R. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant 1987, 2:175-181.
20. Guillemain R, Lavarde V, Amrein C, Chevalier P, Guinvarc'h A, Glotz D. Invasive aspergillosis after transplantation. Transplant Proc 1995, 27:1307-1309.
21. Guillemain R, Lavarde V, Amrein C, Chevalier P, Guinvarc'h A, Glotz D. [Aspergillosis and renal, heart and lung transplantation]. Pathol Biol (Paris) 1994, 42:661-669.
22. Cahill BC, Hibbs JR, Savik K, Juni BA, Dosland BM, Edin-Stibbe C, et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997, 112:1160-1164. 10.1378/chest.112.5.1160, 9367451.
23. Singh N, Wagener MM, Cacciarelli TV, Levitsky J. Antifungal management practices in liver transplant recipients. Am J Transplant 2008, 8:426-431. 10.1111/j.1600-6143.2007.02089.x, 18190655.
24. Kusne S, Torre-Cisneros J, Manez R, Irish W, Martin M, Fung J, et al. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 1992, 166:1379-1383. 10.1093/infdis/166.6.1379, 3022485, 1431256.
25. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987, 106:209-216.
26. Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007, 45:205-216. 10.1086/518852, 17578780.
27. Lau CL, Patterson GA, Palmer SM. Critical care aspects of lung transplantation. J Intensive Care Med 2004, 19:83-104. 10.1177/0885066603261509, 15070519.